Qualys (QLYS) 10-Q2 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2022	Oct. 28, 2022
Document Information [Line Items]
Entity Central Index Key	0001107843
Entity Registrant Name	QUALYS, INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-35662
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0534145
Entity Address, Address Line One	919 E. Hillsdale Boulevard, 4th Floor
Entity Address, City or Town	Foster City
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94404
City Area Code	650
Local Phone Number	801-6100
Title of 12(b) Security	Common stock, $0.001 par value per share
Trading Symbol	QLYS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		37,988,029

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 193,902	$ 137,328
Short-term marketable securities	191,378	267,960
Accounts receivable, net of allowance of $1,085 and $793 as of September 30, 2022 and December 31, 2021, respectively	98,717	108,998
Prepaid expenses and other current assets	38,736	32,112
Total current assets	522,733	546,398
Long-term marketable securities	70,997	111,198
Property and equipment, net	53,935	61,854
Operating leases - right of use asset	31,454	37,016
Deferred tax assets, net	39,802	25,087
Intangible assets, net	2,019	6,545
Goodwill	7,447	7,447
Restricted cash	1,200	1,200
Other noncurrent assets	18,044	17,814
Total assets	747,631	814,559
Current liabilities:
Accounts payable	1,308	1,296
Accrued liabilities	42,816	32,504
Deferred revenues, current	278,947	257,872
Operating lease liabilities, current	10,959	12,608
Total current liabilities	334,030	304,280
Deferred revenues, noncurrent	24,182	32,753
Operating lease liabilities, noncurrent	28,911	35,914
Other noncurrent liabilities	5,322	4,898
Total liabilities	392,445	377,845
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding at September 30, 2022 and December 31, 2021	0	0
Common stock, $0.001 par value; 1,000,000 shares authorized; 38,124 and 39,112 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	38	39
Additional paid-in capital	510,557	477,323
Accumulated other comprehensive income	43	1,007
Accumulated deficit	(155,452)	(41,655)
Total stockholders’ equity	355,186	436,714
Total liabilities and stockholders’ equity	$ 747,631	$ 814,559

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Allowance for doubtful accounts receivable	$ 1,085	$ 793
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par or stated value per share (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000	1,000,000
Common stock, shares issued (in shares)	38,124	39,112
Common stock, shares outstanding (in shares)	38,124	39,112

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 125,561	$ 104,934	$ 358,874	$ 301,392
Cost of revenues	25,992	22,479	75,040	65,711
Gross profit	99,569	82,455	283,834	235,681
Operating expenses:
Research and development	25,478	21,336	73,376	58,890
Sales and marketing	25,047	18,569	68,919	54,328
General and administrative	15,698	10,573	41,665	63,829
Total operating expenses	66,223	50,478	183,960	177,047
Income from operations	33,346	31,977	99,874	58,634
Other income (expense), net:
Interest expense	0	0	0	(4)
Interest income	1,568	525	2,925	1,838
Other income (expense), net	(1,076)	(451)	(3,496)	(775)
Total other income (expense), net	492	74	(571)	1,059
Income before income taxes	33,838	32,051	99,303	59,693
Income tax provision	6,178	4,282	19,637	10,554
Net income	$ 27,660	$ 27,769	$ 79,666	$ 49,139
Net income per share:
Basic (in dollars per share)	$ 0.72	$ 0.71	$ 2.06	$ 1.26
Diluted (in dollars per share)	$ 0.71	$ 0.70	$ 2.01	$ 1.22
Weighted average shares used in computing net income per share:
Basic (in shares)	38,317	38,925	38,680	39,077
Diluted (in shares)	39,220	39,938	39,634	40,147

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income	$ 27,660	$ 27,769	$ 79,666	$ 49,139
Other comprehensive income (loss), net of tax
Net change in unrealized losses on available-for-sale debt securities, net of tax	(492)	(192)	(3,553)	(783)
Net change in unrealized gains on cash flow hedges, net of tax	1,160	1,285	2,589	2,095
Other comprehensive income (loss), net of tax	668	1,093	(964)	1,312
Comprehensive income	$ 28,328	$ 28,862	$ 78,702	$ 50,451

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities:
Net income	$ 79,666	$ 49,139
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	25,773	26,752
Bad debt expense	493	247
Loss on disposal of property and equipment	5	12
Stock-based compensation	37,856	56,218
Amortization of premiums on marketable securities	1,127	2,985
Deferred income taxes	(15,599)	(15,962)
Changes in operating assets and liabilities:
Accounts receivable	9,788	15,665
Prepaid expenses and other assets	(1,412)	(5,460)
Accounts payable	841	200
Accrued liabilities	3,968	9,912
Deferred revenues	12,504	21,033
Net cash provided by operating activities	155,010	160,741
Cash flow from investing activities:
Purchases of marketable securities	(178,788)	(255,051)
Sales and maturities of marketable securities	290,949	295,336
Purchases of property and equipment	(12,391)	(20,089)
Proceeds from disposal of property and equipment	0	6
Purchases of intangible assets	(120)	(1,080)
Net cash provided by investing activities	99,650	19,122
Cash flow from financing activities:
Repurchases of common stock	(212,839)	(94,919)
Proceeds from exercise of stock options	23,161	10,948
Payments for taxes related to net share settlement of equity awards	(12,853)	(24,194)
Proceeds from issuance of common stock through employee stock purchase plan	4,445	0
Principal payments under finance lease obligations	0	(90)
Net cash used in financing activities	(198,086)	(108,255)
Net increase in cash, cash equivalents and restricted cash	56,574	71,608
Cash, cash equivalents and restricted cash at beginning of period	138,528	75,332
Cash, cash equivalents and restricted cash at end of period	$ 195,102	$ 146,940

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balances (in shares) at Dec. 31, 2020		39,253
Balance at Dec. 31, 2020		$ 39	$ 401,359	$ (484)	$ 3,568	$ 404,482
Net income		0	0	0	228	228
Other comprehensive income (loss), net of tax		$ 0	0	604	0	604
Issuance of common stock upon exercise of stock options (in shares)		69
Issuance of common stock upon exercise of stock options		$ 0	2,264	0	0	2,264
Repurchase of common stock (in shares)		(269)
Repurchase of common stock		$ 0	(3,232)	0	(27,797)	(31,029)
Issuance of common stock upon vesting of restricted stock units (in shares)		305
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(155)
Taxes related to net share settlement of equity awards		$ 0	(17,643)	0	0	(17,643)
Stock-based compensation		$ 0	38,202	0	0	38,202
Balances (in shares) at Mar. 31, 2021		39,203
Balance at Mar. 31, 2021		$ 39	420,950	120	(24,001)	397,108
Balances (in shares) at Dec. 31, 2020		39,253
Balance at Dec. 31, 2020		$ 39	401,359	(484)	3,568	404,482
Net income						49,139
Other comprehensive income (loss), net of tax						1,312
Balances (in shares) at Sep. 30, 2021		38,864
Balance at Sep. 30, 2021		$ 39	433,814	828	(31,695)	402,986
Balances (in shares) at Mar. 31, 2021		39,203
Balance at Mar. 31, 2021		$ 39	420,950	120	(24,001)	397,108
Net income		0	0	0	21,142	21,142
Other comprehensive income (loss), net of tax		$ 0	0	(385)	0	(385)
Issuance of common stock upon exercise of stock options (in shares)		57
Issuance of common stock upon exercise of stock options		$ 0	2,174	0	0	2,174
Repurchase of common stock (in shares)		(316)
Repurchase of common stock		$ 0	(3,796)	0	(28,427)	(32,223)
Issuance of common stock upon vesting of restricted stock units (in shares)		84
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(33)
Taxes related to net share settlement of equity awards		$ 0	(3,374)	0	0	(3,374)
Stock-based compensation		$ 0	8,553	0	0	8,553
Balances (in shares) at Jun. 30, 2021		38,995
Balance at Jun. 30, 2021		$ 39	424,507	(265)	(31,286)	392,995
Net income		0	0	0	27,769	27,769
Other comprehensive income (loss), net of tax		$ 0	0	1,093	0	1,093
Issuance of common stock upon exercise of stock options (in shares)		117
Issuance of common stock upon exercise of stock options		$ 0	6,510	0	0	6,510
Repurchase of common stock (in shares)		(290)
Repurchase of common stock		$ 0	(3,489)	0	(28,178)	(31,667)
Issuance of common stock upon vesting of restricted stock units (in shares)		74
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(32)
Taxes related to net share settlement of equity awards		$ 0	(3,177)	0	0	(3,177)
Stock-based compensation		$ 0	9,463	0	0	9,463
Balances (in shares) at Sep. 30, 2021		38,864
Balance at Sep. 30, 2021		$ 39	433,814	828	(31,695)	402,986
Balances (in shares) at Dec. 31, 2021		39,112
Balance at Dec. 31, 2021		$ 39	477,323	1,007	(41,655)	436,714
Net income		0	0	0	25,410	25,410
Other comprehensive income (loss), net of tax		$ 0	0	(1,677)	0	(1,677)
Issuance of common stock upon exercise of stock options (in shares)		66
Issuance of common stock upon exercise of stock options		$ 0	2,569	0	0	2,569
Repurchase of common stock (in shares)		(368)
Repurchase of common stock		$ 0	(4,416)	0	(42,165)	(46,581)
Issuance of common stock upon vesting of restricted stock units (in shares)		70
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(28)
Taxes related to net share settlement of equity awards		$ 0	(3,631)	0	0	(3,631)
Issuance of common stock through employee stock purchase plan (in shares)		23
Issuance of common stock through employee stock purchase plan			2,086			2,086
Stock-based compensation		$ 0	11,745	0	0	11,745
Balances (in shares) at Mar. 31, 2022		38,875
Balance at Mar. 31, 2022		$ 39	485,676	(670)	(58,410)	426,635
Balances (in shares) at Dec. 31, 2021		39,112
Balance at Dec. 31, 2021		$ 39	477,323	1,007	(41,655)	436,714
Net income						79,666
Other comprehensive income (loss), net of tax						$ (964)
Issuance of common stock upon exercise of stock options (in shares)	[1]					429
Balances (in shares) at Sep. 30, 2022		38,124
Balance at Sep. 30, 2022		$ 38	510,557	43	(155,452)	$ 355,186
Balances (in shares) at Mar. 31, 2022		38,875
Balance at Mar. 31, 2022		$ 39	485,676	(670)	(58,410)	426,635
Net income		0	0	0	26,596	26,596
Other comprehensive income (loss), net of tax		$ 0	0	45	0	45
Issuance of common stock upon exercise of stock options (in shares)		146
Issuance of common stock upon exercise of stock options		$ 0	6,504	0	0	6,504
Repurchase of common stock (in shares)		(561)
Repurchase of common stock		$ 0	(6,745)	0	(64,487)	(71,232)
Issuance of common stock upon vesting of restricted stock units (in shares)		90
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(33)
Taxes related to net share settlement of equity awards		$ 0	(4,530)	0	0	(4,530)
Stock-based compensation		$ 0	12,820	0	0	12,820
Balances (in shares) at Jun. 30, 2022		38,517
Balance at Jun. 30, 2022		$ 39	493,725	(625)	(96,301)	396,838
Net income		0	0	0	27,660	27,660
Other comprehensive income (loss), net of tax		$ 0	0	668	0	668
Issuance of common stock upon exercise of stock options (in shares)		217
Issuance of common stock upon exercise of stock options		$ 0	14,088	0	0	14,088
Repurchase of common stock (in shares)		(684)
Repurchase of common stock		$ (1)	(8,214)	0	(86,811)	(95,026)
Issuance of common stock upon vesting of restricted stock units (in shares)		87
Issuance of common stock upon vesting of restricted stock units		$ 0	0	0	0	0
Taxes related to net share settlement of equity awards (in shares)		(36)
Taxes related to net share settlement of equity awards		$ 0	(4,692)	0	0	(4,692)
Issuance of common stock through employee stock purchase plan (in shares)		23
Issuance of common stock through employee stock purchase plan			2,359			2,359
Stock-based compensation		$ 0	13,291	0	0	13,291
Balances (in shares) at Sep. 30, 2022		38,124
Balance at Sep. 30, 2022		$ 38	$ 510,557	$ 43	$ (155,452)	$ 355,186

[1]Included 348 thousand shares of PSOs.

Note 1 - Description of Busines

Note 1 - Description of Business and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	NOTE 1. Description of Business and Summary of Significant Accounting Policies Description of Business Qualys, Inc. (the “Company”, "we", "us", "our") was incorporated in the state of Delaware on December 30, 1999. Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information as well as the instructions to Form 10 December 31, 2021 not three nine September 30, 2022 not December 31, 2022 10 December 31, 2021 February 22, 2022. Risks and Uncertainties In March 2020, 19 19, may may not 19 not 2022, 19 may Additionally, the uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by the supply chain environment, inflationary pressure, rising interest rates, labor shortages, significant volatility of global markets and geopolitical conflicts could have a material adverse effect on the Company's long-term business and could lead to further economic disruption and expose the Company to greater risk as its current and potential customers may Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date of the condensed consolidated financial statements and the reported results of operations during the reporting period. The Company’s management regularly assesses these estimates, which primarily affect revenue recognition, allowance for credit loss, the valuation of goodwill and intangible assets, leases, stock-based compensation and income tax provision. Actual results could differ from those estimates and such differences may Non-Marketable Securities During the fiscal year ended December 31, 2018, not no may not No not Recently Adopted Accounting Pronouncements None. Recently Issued Accounting Pronouncements Not The Company does not not There have been no 1" 10 December 31, 2021.

Note 2 - Fair Value of Financia

Note 2 - Fair Value of Financial Instruments	9 Months Ended
Note 2 - Fair Value of Financial Instruments	Sep. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 2. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For certain of the Company’s financial instruments, including certain cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate their fair values due to the relatively short maturity of these balances. The Company measures and reports certain cash equivalents, marketable securities, derivative foreign currency forward contracts at fair value in accordance with the provisions of the authoritative accounting guidance that addresses fair value measurements. This guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three Level 1 Level 2 Level 3 The Company's financial instruments consist of assets and liabilities measured using Level 1 2 1 2 The Company's cash and cash equivalents, and marketable securities consist of the following: September 30, 2022 Unrealized Unrealized Amortized Cost Gains Losses Fair Value (in thousands) Cash and cash equivalents: Cash $ 46,591 $ — $ — $ 46,591 Money market funds 147,311 — — 147,311 Total 193,902 — — 193,902 Short-term marketable securities: Corporate bonds 33,249 4 (352 ) 32,901 U.S. Treasury and government agencies 159,056 — (1,576 ) 157,480 Foreign government 1,003 — (6 ) 997 Total 193,308 4 (1,934 ) 191,378 Long-term marketable securities: Corporate bonds 35,440 — (1,122 ) 34,318 Asset-backed securities 19,389 — (188 ) 19,201 U.S. Treasury and government agencies 17,977 — (499 ) 17,478 Total 72,806 — (1,809 ) 70,997 Total $ 460,016 $ 4 $ (3,743 ) $ 456,277 December 31, 2021 Unrealized Unrealized Amortized Cost Gains Losses Fair Value (in thousands) Cash and cash equivalents: Cash $ 61,220 $ — $ — $ 61,220 Money market funds 75,258 — — 75,258 Commercial paper 850 — — 850 Total 137,328 — — 137,328 Short-term marketable securities:(1) Commercial paper 18,046 — — 18,046 Corporate bonds 28,869 101 (7 ) 28,963 Asset-backed securities 3,952 — — 3,952 U.S. Treasury and government agencies 217,160 2 (163 ) 216,999 Total 268,027 103 (170 ) 267,960 Long-term marketable securities: Corporate bonds 57,762 160 (182 ) 57,740 Asset-backed securities 14,941 6 (36 ) 14,911 U.S. Treasury and government agencies 37,664 — (136 ) 37,528 Foreign government 1,007 12 — 1,019 Total 111,374 178 (354 ) 111,198 Total $ 516,729 $ 281 $ (524 ) $ 516,486 ( 1 2 10 December 31, 2021. As of September 30, 2022 12 not December 31, 2021, no 12 The following table sets forth by level within the fair value hierarchy the fair value of the Company's cash equivalents and marketable securities measured on a recurring basis: September 30, 2022 Level 1 Level 2 Fair Value (in thousands) Money market funds $ 147,311 $ — $ 147,311 Corporate bonds — 67,219 67,219 Asset-backed securities — 19,201 19,201 U.S. Treasury and government agencies — 174,958 174,958 Foreign government — 997 997 Total $ 147,311 $ 262,375 $ 409,686 December 31, 2021 Level 1 Level 2 Fair Value (in thousands) Money market funds $ 75,258 $ — $ 75,258 Commercial paper — 18,896 18,896 Corporate bonds — 86,703 86,703 Asset-backed securities — 18,863 18,863 U.S. Treasury and government agencies — 254,527 254,527 Foreign government — 1,019 1,019 Total $ 75,258 $ 380,008 $ 455,266 The following summarizes the fair value of marketable securities by contractual maturity: September 30, 2022 Mature within Mature after One Year Mature over One Year through Two Years Two Years Fair Value (in thousands) Corporate bonds $ 32,901 $ 31,706 $ 2,612 $ 67,219 Asset-backed securities — 9,799 9,402 19,201 U.S. Treasury and government agencies 157,480 17,478 — 174,958 Foreign government 997 — — 997 Total $ 191,378 $ 58,983 $ 12,014 $ 262,375 Derivative Financial Instruments Designated cash flow hedges The Company enters into foreign currency forward contracts to reduce the risk of variability in future cash flow due to foreign currency exchange rate fluctuations from certain forecasted subscription revenue orders billed in British Pound ("GBP") and Euro and operating expenses incurred in Indian Rupee ("INR"), which are designated as cash flow hedges. Unrealized foreign exchange gains or losses related to those designated cash flow hedge contracts are recorded in Accumulated other comprehensive income ("AOCI") and will be reclassified into revenues or operating expenses, respectively, in the same periods when the hedged transactions are recognized in earnings. As of September 30, 2022 , the Company had designated cash flow hedge forward contracts with notional amounts of €31.0 £9.6 Rs.3,289.0 December 31, 2021 , the Company had designated cash flow hedge forward contracts with notional amounts of €29.8 £9.4 Rs.2,955.3 September 30, 2022 , a net amount of unrealized gain of $5.3 million before tax on the foreign currency forward contracts for GBP and Euro reported in AOCI is expected to be reclassified into revenue within the next 12 September 30, 2022, 12 Non-designated forward contracts The Company also uses foreign currency forward contracts to hedge certain foreign currency denominated assets or liabilities, which are not As of September 30, 2022 f €26.0 £13.1 Rs.205.0 December 31, 2021 €34.5 £11.6 Rs.74.9 C$2.5 CHF1.0 The following summarizes derivative financial instruments as of September 30, 2022 December 31, 2021 September 30, December 31, 2022 2021 Assets (in thousands) Foreign currency forward contracts designated as cash flow hedge $ 4,898 $ 1,737 Foreign currency forward contracts not designated as hedging instruments 8,276 1,599 Total $ 13,174 $ 3,336 Liabilities Foreign currency forward contracts designated as cash flow hedge $ (1,942 ) $ (181 ) Foreign currency forward contracts not designated as hedging instruments (1,067 ) (207 ) Total $ (3,009 ) $ (388 ) All foreign currency forward contracts were valued at fair value using Level 2 The following summarizes the gains (losses) recognized from forward contracts and other foreign currency transactions in other income (expense), net on the condensed consolidated statements of operations: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Net gains from non-designated forward contracts $ 3,608 $ 748 $ 8,573 $ 1,792 Other foreign currency transaction gains (losses) (4,518 ) (1,132 ) (11,856 ) (2,360 ) Total foreign exchange losses, net (910 ) (384 ) (3,283 ) (568 ) Other expenses (166 ) (67 ) (213 ) (207 ) Other expense, net $ (1,076 ) $ (451 ) $ (3,496 ) $ (775 )

Note 3 - Accumulated Other Comp

Note 3 - Accumulated Other Comprehensive Income (Loss)	9 Months Ended
Note 3 - Accumulated Other Comprehensive Income (Loss)	Sep. 30, 2022
Notes to Financial Statements
Accumulated Other Comprehensive Income Disclosure [Text Block]	NOTE 3. Accumulated Other Comprehensive Income (Loss) The components and changes in accumulated other comprehensive income (loss) for the three nine September 30, 2022 2021 Available-for-sale debt securities Cash flow hedges Total (in thousands) Balances at December 31, 2021 $ (185 ) $ 1,192 $ 1,007 Change in unrealized gains (losses) during the period (2,070 ) 648 (1,422 ) Net gains reclassified into income during the period - (60 ) (60 ) Income tax provision (58 ) (137 ) (195 ) Net change during the period (2,128 ) 451 (1,677 ) Balances at March 31, 2022 (2,313 ) 1,643 (670 ) Change in unrealized gains (losses) during the period (933 ) 1,548 615 Net gains reclassified into income during the period - (244 ) (244 ) Income tax provision - (326 ) (326 ) Net change during the period (933 ) 978 45 Balances at June 30, 2022 (3,246 ) 2,621 (625 ) Change in unrealized gains (losses) during the period (492 ) 1,877 1,385 Net gains reclassified into income during the period - (355 ) (355 ) Income tax provision - (362 ) (362 ) Net change during the period (492 ) 1,160 668 Balances at September 30, 2022 $ (3,738 ) $ 3,781 $ 43 Balances at December 31, 2020 $ 1,224 $ (1,708 ) $ (484 ) Change in unrealized gains (losses) during the period (501 ) 1,092 591 Net losses reclassified into income during the period 8 192 200 Income tax benefit (provision) 104 (291 ) (187 ) Net change during the period (389 ) 993 604 Balances at March 31, 2021 835 (715 ) 120 Change in unrealized losses during the period (273 ) (394 ) (667 ) Net losses reclassified into income during the period 8 152 160 Income tax benefit 63 59 122 Net change during the period (202 ) (183 ) (385 ) Balances at June 30, 2021 633 (898 ) (265 ) Change in unrealized losses during the period (257 ) 1,367 1,110 Net losses reclassified into income during the period 5 318 323 Income tax benefit (provision) 60 (400 ) (340 ) Net change during the period (192 ) 1,285 1,093 Balances at September 30, 2021 $ 441 $ 387 $ 828 The effects on income before income taxes of amounts reclassified from AOCI to the condensed consolidated statements of operations were as follows: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Reclassification of AOCI - Available-for-sale debt securities Other income (expense), net $ — $ (5 ) $ — $ (21 ) Reclassification of AOCI - Cash flow hedges Revenues $ 660 $ (570 ) $ 883 $ (1,243 ) Cost of revenues (67 ) 51 (50 ) 117 Research and development expenses (195 ) 170 (143 ) 391 Sales and marketing expenses (12 ) 9 (9 ) 22 General and administrative expenses (31 ) 22 (22 ) 51 Total $ 355 $ (318 ) $ 659 $ (662 )

Note 4 - Property and Equipment

Note 4 - Property and Equipment, Net	9 Months Ended
Note 4 - Property and Equipment, Net	Sep. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4. Property and Equipment, Net Property and equipment, net, consists of the following: September 30, December 31, 2022 2021 (in thousands) Computer equipment $ 172,966 $ 161,809 Computer software 25,805 25,807 Leasehold improvements 21,009 21,092 Scanner appliances 16,264 16,510 Furniture, fixtures and equipment 6,437 6,479 Total property and equipment 242,481 231,697 Less: accumulated depreciation and amortization (188,546 ) (169,843 ) Property and equipment, net $ 53,935 $ 61,854 As of September 30, 2022 and December 31, 2021 , physical scanner appliances and other computer equipment that are or will be subject to leases by customers had a net carrying value of $6.1 million and $5.3 not $1.3 three September 30, 2022 2021 , respectively, and $20.7 million and $21.2 million for the nine September 30, 2022 2021, were primarily recorded in cost of revenues in the condensed consolidated statements of operations.

Note 5 - Revenue From Contracts

Note 5 - Revenue From Contracts With Customers	9 Months Ended
Note 5 - Revenue From Contracts With Customers	Sep. 30, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	NOTE 5. Revenue from Contracts with Customers The Company records deferred revenue when cash payments are received or due in advance of its performance obligations offset by revenue recognized in the period. Revenues o f $51.4 million and $42.1 million were recognized during the three September 30, 2022 2021 , respectively, which amounts were included in the deferred revenue balances as of December 31, 2021 2020 , respectively. f $227.3 million and $189.1 million were recognized during the nine September 30, 2022 2021 , respectively, which amounts were included in the deferred revenue balances as of December 31, 2021 2020 , respectively. The Company's payment terms vary by the type and location of its customers. The term between invoicing and when payment is due is not The following table sets forth the expected revenue from all remaining performance obligations as of September 30, 2022 (in thousands) 2022 (remaining three months) $ 42,746 2023 136,916 2024 64,517 2025 13,747 2026 934 2027 and thereafter 291 Total $ 259,151 Revenues allocated to remaining performance obligations represents the transaction price of noncancelable orders for which service has not one From time to time, the Company enters into contracts with customers that extend beyond one one not Revenues by sales channel are as follows: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Direct $ 73,235 $ 61,554 $ 209,863 $ 178,288 Partner 52,326 43,380 149,011 123,104 Total $ 125,561 $ 104,934 $ 358,874 $ 301,392 The Company utilizes partners to enable and accelerate the adoption of its cloud platform by increasing its distribution capabilities and market awareness of its cloud platform as well as by targeting geographic regions outside the reach of its direct sales force. The Company's channel partners maintain relationships with their customers throughout the territories in which they operate and provide their customers with services and third may one not 12, Deferred costs to obtain contracts are as follows: September 30, 2022 December 31, 2021 (in thousands) Current $ 4,646 $ 4,223 Noncurrent $ 8,991 $ 8,391 For the three September 30, 2022 2021 , the Company recognized $1.3 million and $1.0 million, respectively, of amortization expense relating to deferred costs to obtain contracts in sales and marketing expense in the condensed consolidated statements of operations. For the nine September 30, 2022 2021 , the Company recognized $3.6 million and $2.8 million, respectively, of amortization expense relating to deferred costs to obtain contracts in sales and marketing expense in the condensed consolidated statements of operations. During the same periods, there was no impairment loss related to the deferred costs to obtain contracts. As of December 31, 2020,

Note 6 - Intangible Assets, Net

Note 6 - Intangible Assets, Net	9 Months Ended
Note 6 - Intangible Assets, Net	Sep. 30, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 6. Intangible Assets, Net Intangible assets consist primarily of developed technology and patent licenses acquired from business or asset acquisitions. Acquired intangibles are amortized on a straight-line basis over the respective estimated useful lives of the assets. The carrying values of intangible assets are as follows: September 30, 2022 Weighted Average Weighted Average Life Remaining Life Accumulated (in thousands) (Years) (Years) Cost Amortization Net Book Value Developed technology 4.5 0.3 $ 28,556 $ (26,768 ) $ 1,788 Patent licenses 14.0 1.9 1,387 (1,196 ) 191 Non-compete agreements 2.0 — 500 (500 ) — Total intangibles subject to amortization $ 30,443 $ (28,464 ) 1,979 Intangible assets not subject to amortization 40 Total intangible assets, net $ 2,019 December 31, 2021 Weighted Average Weighted Average Life Remaining Life Accumulated (in thousands) (Years) (Years) Cost Amortization Net Book Value Developed technology 4.5 0.9 $ 28,556 $ (22,463 ) $ 6,093 Patent licenses 14.0 2.7 1,387 (1,121 ) 266 Non-compete agreements 2.0 0.6 500 (354 ) 146 Total intangibles subject to amortization $ 30,443 $ (23,938 ) 6,505 Intangible assets not subject to amortization 40 Total intangible assets, net $ 6,545 Intangible asset amortization expense was $1 .3 and $1.7 million for the three September 30, 2022 2021 , respectively, and $4.5 million and $5.0 million for the nine September 30, 2022 2021 , respectively . Intangible asset amortization expenses were primarily recorded in cost of revenues in the condensed consolidated statements of operations. As of September 30, 2022 (in thousands) 2022 (remaining three months) $ 537 2023 590 2024 452 2025 240 2026 160 Total expected future amortization expense $ 1,979

Note 7 - Leases

Note 7 - Leases	9 Months Ended
Note 7 - Leases	Sep. 30, 2022
Notes to Financial Statements
Lessee, Operating Leases and Finance Lease [Text Block]	NOTE 7. Leases The Company leases certain offices, computer equipment and its data center facilities under non-cancelable operating leases for varying periods through 2028. not not three September 30, 2022 2021 , respectively, and $11.1 million and $12.5 million for the nine September 30, 2022 2021, Supplemental cash flow information related to operating leases was as follows: Nine Months Ended September 30, 2022 2021 (in thousands) Cash payments included in the measurement of lease liabilities $ 12,258 $ 10,776 Lease liabilities arising from obtaining right-of-use assets $ 3,401 $ 1,739 The weighted average remaining lease term and the weighted average discount rate of the Company's operating leases were as follows: September 30, 2022 December 31, 2021 Weighted average remaining lease term (years) 4.0 4.5 Weighted average discount rate 5.0 % 4.8 %

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	9 Months Ended
Note 8 - Commitments and Contingencies	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 8. Commitments and Contingencies Indemnifications The Company from time to time enters into certain types of contracts that contingently require it to indemnify various parties against claims from third may may not not The Company maintains director and officer insurance, which may

Note 9 - Stockholders' Equity a

Note 9 - Stockholders' Equity and Stock-based Compensation	9 Months Ended
Note 9 - Stockholders' Equity and Stock-based Compensation	Sep. 30, 2022
Notes to Financial Statements
Shareholders' Equity and Share-Based Payments [Text Block]	NOTE 9. Stockholders' Equity and Stock-based Compensation Equity Incentive Plans Restated 2012 On June 8, 2022 ( 2012 2012 2012 2012 2012 2012 2012 2012 no 2012 As of September 30, 2022 , 2,911 thousand shares were available for grant under the Restated 2012 2021 On June 9, 2021, 2021 August 16 February 16 may first During the nine September 30, 2022 , 45.3 thousand shares were issued in connection with the purchase of common stock by participating employees. As of September 30, 2022 , 554.7 thousand shares were available for future purchases. Stock-based Compensation The following table shows a summary of the stock-based compensation expense included in the condensed consolidated statements of operations: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Cost of revenues $ 1,384 $ 986 $ 3,739 $ 2,702 Research and development 3,236 2,723 10,064 7,520 Sales and marketing 2,495 1,642 6,829 4,356 General and administrative 6,176 4,112 17,224 41,640 Total stock-based compensation $ 13,291 $ 9,463 $ 37,856 $ 56,218 As of September 30, 2022 , the Company had unrecognized stock-based compensation expenses of $21.8 million, $66.2 million, $3.3 million, and $0.9 million related to options, RSUs, performance-based RSUs, and ESPP purchase rights, respectively, which are expected to be recognized over weighted-average periods of 2.9 years, 2.7 years, 1.8 years, and 0.4 years, respectively. Performance-based Restricted Stock Units ("PSUs") and Performance-based Stock Options On October 28, 2021, three one 2022, 2023, 2024, first second 100% first second third third 100% second third not September 30, 2022, not no On April 27, 2021, three January 2021 December 2023. 12 100% The Company recognized $1.0 million of stock-based compensation expenses related to all PSUs during the three September 30, 2022, nine September 30, 2022. On March 19, 2021, nine September 30, 2021. Stock Option Activity A summary of the Company’s stock option activity is as follows: Weighted Weighted Average Outstanding Average Remaining Aggregate Options Exercise Price Contractual Life Intrinsic Value (in thousands) (Years) (in thousands) Balance as of December 31, 2021 1,838 $ 66.05 6.0 $ 130,791 Granted 438 $ 130.97 Exercised (429 ) $ 54.00 Canceled (122 ) $ 112.66 Balance as of September 30, 2022 1,725 $ 82.24 6.5 $ 67,404 Vested and expected to vest - September 30, 2022 1,512 $ 76.56 6.1 $ 66,670 Exercisable - September 30, 2022 948 $ 50.98 4.3 $ 63,624 Restricted Stock Unit Activity A summary of the Company’s RSU activity is as follows: Weighted Average Grant Date Outstanding Fair Value RSUs Per Share (in thousands) Balance as of December 31, 2021 917 (1) $ 104.78 Granted 278 $ 133.00 Vested (248 ) $ 99.25 Canceled (122 ) $ 116.40 Balance as of September 30, 2022 825 (1) $ 114.13 Outstanding and expected to vest - September 30, 2022 700 $ 112.22 ( 1 2021. Share Repurchase Program The Company's share repurchase program was authorized by the board of directors as follows: Announcement Date Authorized Dollar Value (in millions) February 12, 2018 $ 100.0 October 30, 2018 100.0 October 30, 2019 100.0 May 7, 2020 100.0 February 10, 2021 100.0 November 3, 2021 200.0 May 4, 2022 200.0 Total as of September 30, 2022 $ 900.0 Shares may 10b 18 1934, 10b5 1 first During the nine September 30, 2022 2021, September 30, 2022

Note 10 - Net Income Per Share

Note 10 - Net Income Per Share	9 Months Ended
Note 10 - Net Income Per Share	Sep. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 10. Net Income Per Share The computations for basic and diluted net income per share are as follows: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands, except per share data) (in thousands, except per share data) Numerator: Net income $ 27,660 $ 27,769 $ 79,666 $ 49,139 Denominator: Basic weighted average shares 38,317 38,925 38,680 39,077 Effect of potentially dilutive shares: Stock options 658 852 715 851 Restricted stock units 242 161 236 219 Employee stock purchase plan 3 — 3 — Diluted weighted average shares 39,220 39,938 39,634 40,147 Net income per share: Basic $ 0.72 $ 0.71 $ 2.06 $ 1.26 Diluted $ 0.71 $ 0.70 $ 2.01 $ 1.22 Potentially dilutive shares not Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Stock options 554 543 614 531 Restricted stock units — 50 30 81 Employee stock purchase plan 13 1 7 — Total anti-dilutive shares 567 594 651 612

Note 11 - Income Taxes

Note 11 - Income Taxes	9 Months Ended
Note 11 - Income Taxes	Sep. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 11. Income Taxes The Company's income tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. The Company's quarterly tax provision, and estimate of its annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how the Company does business, tax law developments and possible outcomes of audits. The Company's estimated effective tax rate for the year differs from the U.S. statutory rate of 21% The Company recorded an income tax provision of $6.2 million and $4.3 million for the three September 30, 2022 2021 , respectively, resulting in an effective tax rate of 18.3% and 13.4%, respectively. The increase in income tax provision for the three September 30, 2022 compared to the three September 30, 2021 was primarily due to an increase in pre-tax income and the effects of a tax law change related to mandatory capitalization of research and development expenses starting January 1, 2022, The Company recorded an income tax provision of $19.6 million and $10.6 million for the nine September 30, 2022 2021 , respectively, resulting in an effective tax rate of 19.8% and 17.7%, respectively. The increase in income tax provision for the nine September 30, 2022 compared to the nine September 30, 2021 was primarily due to January 1, 2022, nine September 30, 2021, As of September 30, 2022 , the Company had unrecognized tax benefits of $10.3 million, of which $5.3 million, if recognized, would favorably impact the Company's effective tax rate. As of December 31, 2021 , the Company had unrecognized tax benefits of $9.7 million, of which $4.9 million, if recognized, would favorably impact the Company's effective tax rate. The Company does not 12 On June 29, 2020, 2020 $5 2020, 2021 2022. not three nine September 30, 2022 2020

Note 12 - Segment Information a

Note 12 - Segment Information and Information About Geographic Area	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 12. Segment Information and Information about Geographic Area Under ASC 280 one one Revenue by geographic area, based on the customer's billing address, is as follows: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) United States $ 75,234 $ 63,599 $ 214,318 $ 184,722 Foreign 50,327 41,335 144,556 116,670 Total revenues $ 125,561 $ 104,934 $ 358,874 $ 301,392 Long-lived assets, which consist of Property and equipment, net and Operating leases - right of use asset, by geographic area, are as follows: September 30, December 31, 2022 2021 (in thousands) United States $ 60,174 $ 66,440 India 17,515 20,401 Rest of world 7,700 12,029 Total $ 85,389 $ 98,870

Note 13 - Subsequent Events

Note 13 - Subsequent Events	9 Months Ended
Note 13 - Subsequent Events	Sep. 30, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 13. Subsequent Events On October 4, 2022 , third 18 10 not

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2022
Accounting Policies [Abstract]
Description Of Business Policy [Policy Text Block]	Description of Business Qualys, Inc. (the “Company”, "we", "us", "our") was incorporated in the state of Delaware on December 30, 1999.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information as well as the instructions to Form 10 December 31, 2021 not three nine September 30, 2022 not December 31, 2022 10 December 31, 2021 February 22, 2022.
Risk and Uncertainties, Policy [Policy Text Block]	Risks and Uncertainties In March 2020, 19 19, may may not 19 not 2022, 19 may Additionally, the uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by the supply chain environment, inflationary pressure, rising interest rates, labor shortages, significant volatility of global markets and geopolitical conflicts could have a material adverse effect on the Company's long-term business and could lead to further economic disruption and expose the Company to greater risk as its current and potential customers may
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date of the condensed consolidated financial statements and the reported results of operations during the reporting period. The Company’s management regularly assesses these estimates, which primarily affect revenue recognition, allowance for credit loss, the valuation of goodwill and intangible assets, leases, stock-based compensation and income tax provision. Actual results could differ from those estimates and such differences may
Securities Owned Not Readily Marketable, Policy [Policy Text Block]	Non-Marketable Securities During the fiscal year ended December 31, 2018, not no may not No not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements None. Recently Issued Accounting Pronouncements Not The Company does not not There have been no 1" 10 December 31, 2021.

Note 2 - Fair Value of Financ_2

Note 2 - Fair Value of Financial Instruments (Tables)	9 Months Ended
Note 2 - Fair Value of Financial Instruments (Tables)	Sep. 30, 2022
Notes Tables
Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost to Fair Value [Table Text Block]	September 30, 2022 Unrealized Unrealized Amortized Cost Gains Losses Fair Value (in thousands) Cash and cash equivalents: Cash $ 46,591 $ — $ — $ 46,591 Money market funds 147,311 — — 147,311 Total 193,902 — — 193,902 Short-term marketable securities: Corporate bonds 33,249 4 (352 ) 32,901 U.S. Treasury and government agencies 159,056 — (1,576 ) 157,480 Foreign government 1,003 — (6 ) 997 Total 193,308 4 (1,934 ) 191,378 Long-term marketable securities: Corporate bonds 35,440 — (1,122 ) 34,318 Asset-backed securities 19,389 — (188 ) 19,201 U.S. Treasury and government agencies 17,977 — (499 ) 17,478 Total 72,806 — (1,809 ) 70,997 Total $ 460,016 $ 4 $ (3,743 ) $ 456,277 December 31, 2021 Unrealized Unrealized Amortized Cost Gains Losses Fair Value (in thousands) Cash and cash equivalents: Cash $ 61,220 $ — $ — $ 61,220 Money market funds 75,258 — — 75,258 Commercial paper 850 — — 850 Total 137,328 — — 137,328 Short-term marketable securities:(1) Commercial paper 18,046 — — 18,046 Corporate bonds 28,869 101 (7 ) 28,963 Asset-backed securities 3,952 — — 3,952 U.S. Treasury and government agencies 217,160 2 (163 ) 216,999 Total 268,027 103 (170 ) 267,960 Long-term marketable securities: Corporate bonds 57,762 160 (182 ) 57,740 Asset-backed securities 14,941 6 (36 ) 14,911 U.S. Treasury and government agencies 37,664 — (136 ) 37,528 Foreign government 1,007 12 — 1,019 Total 111,374 178 (354 ) 111,198 Total $ 516,729 $ 281 $ (524 ) $ 516,486
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	September 30, 2022 Level 1 Level 2 Fair Value (in thousands) Money market funds $ 147,311 $ — $ 147,311 Corporate bonds — 67,219 67,219 Asset-backed securities — 19,201 19,201 U.S. Treasury and government agencies — 174,958 174,958 Foreign government — 997 997 Total $ 147,311 $ 262,375 $ 409,686 December 31, 2021 Level 1 Level 2 Fair Value (in thousands) Money market funds $ 75,258 $ — $ 75,258 Commercial paper — 18,896 18,896 Corporate bonds — 86,703 86,703 Asset-backed securities — 18,863 18,863 U.S. Treasury and government agencies — 254,527 254,527 Foreign government — 1,019 1,019 Total $ 75,258 $ 380,008 $ 455,266
Investments Classified by Contractual Maturity Date [Table Text Block]	September 30, 2022 Mature within Mature after One Year Mature over One Year through Two Years Two Years Fair Value (in thousands) Corporate bonds $ 32,901 $ 31,706 $ 2,612 $ 67,219 Asset-backed securities — 9,799 9,402 19,201 U.S. Treasury and government agencies 157,480 17,478 — 174,958 Foreign government 997 — — 997 Total $ 191,378 $ 58,983 $ 12,014 $ 262,375
Schedule of Derivative Instruments [Table Text Block]	September 30, December 31, 2022 2021 Assets (in thousands) Foreign currency forward contracts designated as cash flow hedge $ 4,898 $ 1,737 Foreign currency forward contracts not designated as hedging instruments 8,276 1,599 Total $ 13,174 $ 3,336 Liabilities Foreign currency forward contracts designated as cash flow hedge $ (1,942 ) $ (181 ) Foreign currency forward contracts not designated as hedging instruments (1,067 ) (207 ) Total $ (3,009 ) $ (388 )
Derivative Instruments, Gain (Loss) [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Net gains from non-designated forward contracts $ 3,608 $ 748 $ 8,573 $ 1,792 Other foreign currency transaction gains (losses) (4,518 ) (1,132 ) (11,856 ) (2,360 ) Total foreign exchange losses, net (910 ) (384 ) (3,283 ) (568 ) Other expenses (166 ) (67 ) (213 ) (207 ) Other expense, net $ (1,076 ) $ (451 ) $ (3,496 ) $ (775 )

Note 3 - Accumulated Other Co_2

Note 3 - Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Available-for-sale debt securities Cash flow hedges Total (in thousands) Balances at December 31, 2021 $ (185 ) $ 1,192 $ 1,007 Change in unrealized gains (losses) during the period (2,070 ) 648 (1,422 ) Net gains reclassified into income during the period - (60 ) (60 ) Income tax provision (58 ) (137 ) (195 ) Net change during the period (2,128 ) 451 (1,677 ) Balances at March 31, 2022 (2,313 ) 1,643 (670 ) Change in unrealized gains (losses) during the period (933 ) 1,548 615 Net gains reclassified into income during the period - (244 ) (244 ) Income tax provision - (326 ) (326 ) Net change during the period (933 ) 978 45 Balances at June 30, 2022 (3,246 ) 2,621 (625 ) Change in unrealized gains (losses) during the period (492 ) 1,877 1,385 Net gains reclassified into income during the period - (355 ) (355 ) Income tax provision - (362 ) (362 ) Net change during the period (492 ) 1,160 668 Balances at September 30, 2022 $ (3,738 ) $ 3,781 $ 43 Balances at December 31, 2020 $ 1,224 $ (1,708 ) $ (484 ) Change in unrealized gains (losses) during the period (501 ) 1,092 591 Net losses reclassified into income during the period 8 192 200 Income tax benefit (provision) 104 (291 ) (187 ) Net change during the period (389 ) 993 604 Balances at March 31, 2021 835 (715 ) 120 Change in unrealized losses during the period (273 ) (394 ) (667 ) Net losses reclassified into income during the period 8 152 160 Income tax benefit 63 59 122 Net change during the period (202 ) (183 ) (385 ) Balances at June 30, 2021 633 (898 ) (265 ) Change in unrealized losses during the period (257 ) 1,367 1,110 Net losses reclassified into income during the period 5 318 323 Income tax benefit (provision) 60 (400 ) (340 ) Net change during the period (192 ) 1,285 1,093 Balances at September 30, 2021 $ 441 $ 387 $ 828
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Reclassification of AOCI - Available-for-sale debt securities Other income (expense), net $ — $ (5 ) $ — $ (21 ) Reclassification of AOCI - Cash flow hedges Revenues $ 660 $ (570 ) $ 883 $ (1,243 ) Cost of revenues (67 ) 51 (50 ) 117 Research and development expenses (195 ) 170 (143 ) 391 Sales and marketing expenses (12 ) 9 (9 ) 22 General and administrative expenses (31 ) 22 (22 ) 51 Total $ 355 $ (318 ) $ 659 $ (662 )

Note 4 - Property and Equipme_2

Note 4 - Property and Equipment, Net (Tables)	9 Months Ended
Note 4 - Property and Equipment, Net (Tables)	Sep. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, December 31, 2022 2021 (in thousands) Computer equipment $ 172,966 $ 161,809 Computer software 25,805 25,807 Leasehold improvements 21,009 21,092 Scanner appliances 16,264 16,510 Furniture, fixtures and equipment 6,437 6,479 Total property and equipment 242,481 231,697 Less: accumulated depreciation and amortization (188,546 ) (169,843 ) Property and equipment, net $ 53,935 $ 61,854

Note 5 - Revenue From Contrac_2

Note 5 - Revenue From Contracts With Customers (Tables)	9 Months Ended
Note 5 - Revenue From Contracts With Customers (Tables)	Sep. 30, 2022
Notes Tables
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	(in thousands) 2022 (remaining three months) $ 42,746 2023 136,916 2024 64,517 2025 13,747 2026 934 2027 and thereafter 291 Total $ 259,151
Disaggregation of Revenue [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Direct $ 73,235 $ 61,554 $ 209,863 $ 178,288 Partner 52,326 43,380 149,011 123,104 Total $ 125,561 $ 104,934 $ 358,874 $ 301,392
Contract With Customer, Commission Asset Balances [Table Text Block]	September 30, 2022 December 31, 2021 (in thousands) Current $ 4,646 $ 4,223 Noncurrent $ 8,991 $ 8,391

Note 6 - Intangible Assets, N_2

Note 6 - Intangible Assets, Net (Tables)	9 Months Ended
Note 6 - Intangible Assets, Net (Tables)	Sep. 30, 2022
Notes Tables
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	September 30, 2022 Weighted Average Weighted Average Life Remaining Life Accumulated (in thousands) (Years) (Years) Cost Amortization Net Book Value Developed technology 4.5 0.3 $ 28,556 $ (26,768 ) $ 1,788 Patent licenses 14.0 1.9 1,387 (1,196 ) 191 Non-compete agreements 2.0 — 500 (500 ) — Total intangibles subject to amortization $ 30,443 $ (28,464 ) 1,979 Intangible assets not subject to amortization 40 Total intangible assets, net $ 2,019 December 31, 2021 Weighted Average Weighted Average Life Remaining Life Accumulated (in thousands) (Years) (Years) Cost Amortization Net Book Value Developed technology 4.5 0.9 $ 28,556 $ (22,463 ) $ 6,093 Patent licenses 14.0 2.7 1,387 (1,121 ) 266 Non-compete agreements 2.0 0.6 500 (354 ) 146 Total intangibles subject to amortization $ 30,443 $ (23,938 ) 6,505 Intangible assets not subject to amortization 40 Total intangible assets, net $ 6,545
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	(in thousands) 2022 (remaining three months) $ 537 2023 590 2024 452 2025 240 2026 160 Total expected future amortization expense $ 1,979

Note 7 - Leases (Tables)

Note 7 - Leases (Tables)	9 Months Ended
Note 7 - Leases (Tables)	Sep. 30, 2022
Notes Tables
Lessee, Operating Lease, Supplemental Cash Flow Disclosure [Table Text Block]	Nine Months Ended September 30, 2022 2021 (in thousands) Cash payments included in the measurement of lease liabilities $ 12,258 $ 10,776 Lease liabilities arising from obtaining right-of-use assets $ 3,401 $ 1,739
Lessee, Weighted Average Remaining Lease Term and Weighted Average Discount Rate [Table Text Block]	September 30, 2022 December 31, 2021 Weighted average remaining lease term (years) 4.0 4.5 Weighted average discount rate 5.0 % 4.8 %

Note 9 - Stockholders' Equity_2

Note 9 - Stockholders' Equity and Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Cost of revenues $ 1,384 $ 986 $ 3,739 $ 2,702 Research and development 3,236 2,723 10,064 7,520 Sales and marketing 2,495 1,642 6,829 4,356 General and administrative 6,176 4,112 17,224 41,640 Total stock-based compensation $ 13,291 $ 9,463 $ 37,856 $ 56,218
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Weighted Average Outstanding Average Remaining Aggregate Options Exercise Price Contractual Life Intrinsic Value (in thousands) (Years) (in thousands) Balance as of December 31, 2021 1,838 $ 66.05 6.0 $ 130,791 Granted 438 $ 130.97 Exercised (429 ) $ 54.00 Canceled (122 ) $ 112.66 Balance as of September 30, 2022 1,725 $ 82.24 6.5 $ 67,404 Vested and expected to vest - September 30, 2022 1,512 $ 76.56 6.1 $ 66,670 Exercisable - September 30, 2022 948 $ 50.98 4.3 $ 63,624
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted Average Grant Date Outstanding Fair Value RSUs Per Share (in thousands) Balance as of December 31, 2021 917 (1) $ 104.78 Granted 278 $ 133.00 Vested (248 ) $ 99.25 Canceled (122 ) $ 116.40 Balance as of September 30, 2022 825 (1) $ 114.13 Outstanding and expected to vest - September 30, 2022 700 $ 112.22
Share Repurchase Program [Table Text Block]	Announcement Date Authorized Dollar Value (in millions) February 12, 2018 $ 100.0 October 30, 2018 100.0 October 30, 2019 100.0 May 7, 2020 100.0 February 10, 2021 100.0 November 3, 2021 200.0 May 4, 2022 200.0 Total as of September 30, 2022 $ 900.0

Note 10 - Net Income Per Share

Note 10 - Net Income Per Share (Tables)	9 Months Ended
Note 10 - Net Income Per Share (Tables)	Sep. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands, except per share data) (in thousands, except per share data) Numerator: Net income $ 27,660 $ 27,769 $ 79,666 $ 49,139 Denominator: Basic weighted average shares 38,317 38,925 38,680 39,077 Effect of potentially dilutive shares: Stock options 658 852 715 851 Restricted stock units 242 161 236 219 Employee stock purchase plan 3 — 3 — Diluted weighted average shares 39,220 39,938 39,634 40,147 Net income per share: Basic $ 0.72 $ 0.71 $ 2.06 $ 1.26 Diluted $ 0.71 $ 0.70 $ 2.01 $ 1.22
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Stock options 554 543 614 531 Restricted stock units — 50 30 81 Employee stock purchase plan 13 1 7 — Total anti-dilutive shares 567 594 651 612

Note 12 - Segment Information_2

Note 12 - Segment Information and Information About Geographic Area (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) (in thousands) United States $ 75,234 $ 63,599 $ 214,318 $ 184,722 Foreign 50,327 41,335 144,556 116,670 Total revenues $ 125,561 $ 104,934 $ 358,874 $ 301,392 September 30, December 31, 2022 2021 (in thousands) United States $ 60,174 $ 66,440 India 17,515 20,401 Rest of world 7,700 12,029 Total $ 85,389 $ 98,870

Note 1 - Description of Busin_2

Note 1 - Description of Business and Summary of Significant Accounting Policies (Details Textual) - Preferred Stock [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2018
Investments, Total		$ 2,500
Other than Temporary Impairment Losses, Investments, Total		$ 0
Proceeds from Dividends Received	$ 0

Note 2 - Fair Value of Financ_3

Note 2 - Fair Value of Financial Instruments (Details Textual) $ in Thousands, € in Millions, ₨ in Millions, £ in Millions, SFr in Millions, $ in Millions	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Sep. 30, 2022 GBP (£)	Sep. 30, 2022 INR (₨)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 GBP (£)	Dec. 31, 2021 INR (₨)	Dec. 31, 2021 CAD ($)	Dec. 31, 2021 CHF (SFr)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	$ 573
Foreign Exchange Contract [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedging [Member]
Derivative, Notional Amount		€ 31	£ 9.6	₨ 3,289	€ 29.8	£ 9.4	₨ 2,955.3
Foreign Exchange Contract [Member] \| Not Designated as Hedging Instrument [Member]
Derivative, Notional Amount		€ 26	£ 13.1	₨ 205	€ 34.5	£ 11.6	₨ 74.9	$ 2.5	SFr 1
Foreign Exchange Contracts for GBP and Euro [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedging [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	5,300
Foreign Exchange Contracts for INR [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedging [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	$ 1,900

Note 2 - Fair Value of Financ_4

Note 2 - Fair Value of Financial Instruments - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cash and cash equivalents	$ 193,902	$ 137,328
Cash and cash equivalents	193,902	137,328
Cash and cash equivalents, unrealized loss	0
Short-term marketable securities, amortization cost	193,308	268,027
Unrealized gains, short-term securities	4	103
Short-term marketable securities, unrealized loss	(1,934)	(170)
Short-term marketable securities	191,378	267,960
Long-term marketable securities, amortization cost	72,806	111,374
Unrealized gains, long-term securities	0	178
Long-term marketable securities, unrealized loss	(1,809)	(354)
Long-term marketable securities	70,997	111,198
Cash and cash equivalents and marketable securities, amortization cost	460,016	516,729
Unrealized gains, securities	4	281
Unrealized loss, securities	(3,743)	(524)
Cash and cash equivalents and short-term and long-term Marketable Securities, fair value	456,277	516,486
Corporate Debt Securities [Member]
Short-term marketable securities, amortization cost	33,249	28,869
Unrealized gains, short-term securities	4	101
Short-term marketable securities, unrealized loss	(352)	(7)
Short-term marketable securities	32,901	28,963
Long-term marketable securities, amortization cost	35,440	57,762
Unrealized gains, long-term securities	0	160
Long-term marketable securities, unrealized loss	(1,122)	(182)
Long-term marketable securities	34,318	57,740
US Government Agencies Debt Securities [Member]
Short-term marketable securities, amortization cost	159,056	217,160
Unrealized gains, short-term securities	0	2
Short-term marketable securities, unrealized loss	(1,576)	(163)
Short-term marketable securities	157,480	216,999
Long-term marketable securities, amortization cost	17,977	37,664
Unrealized gains, long-term securities	0	0
Long-term marketable securities, unrealized loss	(499)	(136)
Long-term marketable securities	17,478	37,528
Commercial Paper, Not Included with Cash and Cash Equivalents [Member]
Short-term marketable securities, amortization cost		18,046
Unrealized gains, short-term securities		0
Short-term marketable securities, unrealized loss		0
Short-term marketable securities		18,046
Foreign Government Agencies [Member]
Long-term marketable securities, amortization cost	1,003	1,007
Unrealized gains, long-term securities	0	12
Long-term marketable securities, unrealized loss	(6)	0
Long-term marketable securities	997	1,019
Asset-Backed Securities [Member]
Short-term marketable securities, amortization cost	19,389	3,952
Unrealized gains, short-term securities	0	0
Short-term marketable securities, unrealized loss	(188)	0
Short-term marketable securities	19,201	3,952
Long-term marketable securities, amortization cost		14,941
Unrealized gains, long-term securities		6
Long-term marketable securities, unrealized loss		(36)
Long-term marketable securities		14,911
Cash [Member]
Cash and cash equivalents	46,591	61,220
Cash and cash equivalents	46,591
Money Market Funds [Member]
Cash and cash equivalents	147,311	75,258
Cash and cash equivalents	$ 147,311
Commercial Paper [Member]
Cash and cash equivalents		$ 850

Note 2 - Fair Value of Financ_5

Note 2 - Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Money market funds	$ 147,311	$ 75,258
Corporate bonds	67,219	86,703
Asset-backed securities	19,201	18,863
U.S. Treasury and government agencies	174,958	254,527
Foreign government	997	1,019
Total	409,686	455,266
Commercial paper		18,896
Fair Value, Inputs, Level 1 [Member]
Money market funds	147,311	75,258
Corporate bonds	0	0
Asset-backed securities	0	0
U.S. Treasury and government agencies	0	0
Foreign government	0	0
Total	147,311	75,258
Commercial paper		0
Fair Value, Inputs, Level 2 [Member]
Money market funds	0	0
Corporate bonds	67,219	86,703
Asset-backed securities	19,201	18,863
U.S. Treasury and government agencies	174,958	254,527
Foreign government	997	1,019
Total	$ 262,375	380,008
Commercial paper		$ 18,896

Note 2 - Fair Value of Financ_6

Note 2 - Fair Value of Financial Instruments - Summary of the Fair Value of Marketable Securities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Available-for-sale Securities, Debt and Equity Maturities, Next Twelve Months, Fair Value	$ 191,378
Available-for-sale Securities, Debt and Equity Maturities, Year One through Two, Fair Value	58,983
Available-for-sale Securities, Debt and Equity Maturities, Year over two years, Fair Value	12,014
Debt Securities, Available-for-sale	262,375
Corporate Bond Securities [Member]
Available-for-sale Securities, Debt and Equity Maturities, Next Twelve Months, Fair Value	32,901
Available-for-sale Securities, Debt and Equity Maturities, Year One through Two, Fair Value	31,706
Available-for-sale Securities, Debt and Equity Maturities, Year over two years, Fair Value	2,612
Debt Securities, Available-for-sale	67,219
Asset-Backed Securities [Member]
Available-for-sale Securities, Debt and Equity Maturities, Next Twelve Months, Fair Value	0
Available-for-sale Securities, Debt and Equity Maturities, Year One through Two, Fair Value	9,799
Available-for-sale Securities, Debt and Equity Maturities, Year over two years, Fair Value	9,402
Debt Securities, Available-for-sale	19,201
US Government Agencies Debt Securities [Member]
Available-for-sale Securities, Debt and Equity Maturities, Next Twelve Months, Fair Value	157,480
Available-for-sale Securities, Debt and Equity Maturities, Year One through Two, Fair Value	17,478
Available-for-sale Securities, Debt and Equity Maturities, Year over two years, Fair Value	0
Debt Securities, Available-for-sale	174,958
Foreign Government Agencies [Member]
Available-for-sale Securities, Debt and Equity Maturities, Next Twelve Months, Fair Value	997
Available-for-sale Securities, Debt and Equity Maturities, Year One through Two, Fair Value	0
Available-for-sale Securities, Debt and Equity Maturities, Year over two years, Fair Value	0
Debt Securities, Available-for-sale	$ 997

Note 2 - Fair Value of Financ_7

Note 2 - Fair Value of Financial Instruments - Summary of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Foreign currency forward contracts	$ 13,174	$ 3,336
Foreign currency forward contracts	(3,009)	(388)
Designated as Hedging Instrument [Member]
Foreign currency forward contracts	4,898	1,737
Foreign currency forward contracts	(1,942)	(181)
Not Designated as Hedging Instrument [Member]
Foreign currency forward contracts	8,276	1,599
Foreign currency forward contracts	$ (1,067)	$ (207)

Note 2 - Fair Value of Financ_8

Note 2 - Fair Value of Financial Instruments - Amounts Recognized In Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net gains from non-designated forward contracts	$ 3,608	$ 748	$ 8,573	$ 1,792
Other foreign currency transaction gains (losses)	(4,518)	(1,132)	(11,856)	(2,360)
Total foreign exchange losses, net	(910)	(384)	(3,283)	(568)
Other expenses	(166)	(67)	(213)	(207)
Other expense, net	$ (1,076)	$ (451)	$ (3,496)	$ (775)

Note 3 - Accumulated Other Co_3

Note 3 - Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Balance	$ 396,838	$ 426,635	$ 436,714	$ 392,995	$ 397,108	$ 404,482	$ 436,714	$ 404,482
Other comprehensive income (loss), net of tax	668	45	(1,677)	1,093	(385)	604	(964)	1,312
Balance	355,186	396,838	426,635	402,986	392,995	397,108	355,186	402,986
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Balance	(3,246)	(2,313)	(185)	633	835	1,224	(185)	1,224
Change in unrealized gains (losses) during the period	(492)	(933)	(2,070)	(257)	(273)	(501)
Net gains reclassified into income during the period	0	0	0	5	8	8
Income tax provision	0	0	(58)	60	63	104
Other comprehensive income (loss), net of tax	(492)	(933)	(2,128)	(192)	(202)	(389)
Balance	(3,738)	(3,246)	(2,313)	441	633	835	(3,738)	441
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Balance	2,621	1,643	1,192	(898)	(715)	(1,708)	1,192	(1,708)
Change in unrealized gains (losses) during the period	1,877	1,548	648	1,367	(394)	1,092
Net gains reclassified into income during the period	(355)	(244)	(60)	318	152	192
Income tax provision	(362)	(326)	(137)	(400)	59	(291)
Other comprehensive income (loss), net of tax	1,160	978	451	1,285	(183)	993
Balance	3,781	2,621	1,643	387	(898)	(715)	3,781	387
AOCI Attributable to Parent [Member]
Balance	(625)	(670)	1,007	(265)	120	(484)	1,007	(484)
Change in unrealized gains (losses) during the period	1,385	615	(1,422)	1,110	(667)	591
Net gains reclassified into income during the period	(355)	(244)	(60)	323	160	200
Income tax provision	(362)	(326)	(195)	(340)	122	(187)
Other comprehensive income (loss), net of tax	668	45	(1,677)	1,093	(385)	604
Balance	$ 43	$ (625)	$ (670)	$ 828	$ (265)	$ 120	$ 43	$ 828

Note 3 - Accumulated Other Co_4

Note 3 - Accumulated Other Comprehensive Income (Loss) - Amounts Reclassified from AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other income (expense), net	$ 1,076	$ 451	$ 3,496	$ 775
Revenues	125,561	104,934	358,874	301,392
Cost of revenues	25,992	22,479	75,040	65,711
Research and development	25,478	21,336	73,376	58,890
Sales and marketing	25,047	18,569	68,919	54,328
General and administrative	15,698	10,573	41,665	63,829
Reclassification out of Accumulated Other Comprehensive Income [Member] \| AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Other income (expense), net	0	(5)	0	(21)
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Revenues	660	(570)	883	(1,243)
Cost of revenues	(67)	51	(50)	117
Research and development	(195)	170	(143)	391
Sales and marketing	(12)	9	(9)	22
General and administrative	(31)	22	(22)	51
Total	$ 355	$ (318)	$ 659	$ (662)

Note 4 - Property and Equipme_3

Note 4 - Property and Equipment, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment, Net, Total	$ 53,935		$ 53,935		$ 61,854
Depreciation, Depletion And Amortization, Excluding Intangible Asset Amortization	6,700	$ 7,000	20,700	$ 21,200
Scanner Appliances and Other Computer Equipment Subject To Subscription [Member]
Property, Plant and Equipment, Net, Total	6,100		6,100		5,300
Scanner Appliances and Other Computer Equipment Not Placed In Service [Member]
Property, Plant and Equipment, Net, Total	$ 3,300		$ 3,300		$ 1,300

Note 4 - Property and Equipme_4

Note 4 - Property and Equipment, Net - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property and equipment and finance lease	$ 242,481	$ 231,697
Less: accumulated depreciation and amortization	(188,546)	(169,843)
Property and equipment and finance lease, net	53,935	61,854
Computer Equipment [Member]
Property and equipment and finance lease	172,966	161,809
Computer Software, Intangible Asset [Member]
Property and equipment and finance lease	25,805	25,807
Leasehold Improvements [Member]
Property and equipment and finance lease	21,009	21,092
Scanner Appliances [Member]
Property and equipment and finance lease	16,264	16,510
Furniture and Fixtures [Member]
Property and equipment and finance lease	$ 6,437	$ 6,479

Note 5 - Revenue From Contrac_3

Note 5 - Revenue From Contracts With Customers (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Contract with Customer, Liability, Revenue Recognized	$ 51,400	$ 42,100	$ 227,300	$ 189,100
Amortization of Deferred Sales Commissions	1,300	1,000	3,600	2,800
Capitalized Contract Cost, Impairment Loss	0	$ 0	0	$ 0
Accounts Receivable, after Allowance for Credit Loss, Current, Total	98,717		98,717		$ 108,998	$ 100,200
Contract with Customer, Liability, Current	278,947		278,947		257,872	213,500
Contract with Customer, Liability, Noncurrent	$ 24,182		$ 24,182		$ 32,753	$ 30,500

Note 5 - Revenue From Contrac_4

Note 5 - Revenue From Contracts With Customers - Expected Revenue from All Remaining Performance Obligations (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Remaining performance obligations	$ 259,151

Note 5 - Revenue From Contrac_5

Note 5 - Revenue From Contracts With Customers - Expected Revenue from All Remaining Performance Obligations 2 (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Remaining performance obligations	$ 259,151
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Remaining performance obligations, period (Year)	3 months
Remaining performance obligations	$ 42,746
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations, period (Year)	1 year
Remaining performance obligations	$ 136,916
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations, period (Year)	1 year
Remaining performance obligations	$ 64,517
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations, period (Year)	1 year
Remaining performance obligations	$ 13,747
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations, period (Year)	1 year
Remaining performance obligations	$ 934
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Remaining performance obligations, period (Year)	1 year
Remaining performance obligations	$ 291

Note 5 - Revenue From Contrac_6

Note 5 - Revenue From Contracts With Customers - Revenue by Sales Channel (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 125,561	$ 104,934	$ 358,874	$ 301,392
Sales Channel, Directly to Consumer [Member]
Revenues	73,235	61,554	209,863	178,288
Sales Channel, Through Intermediary [Member]
Revenues	$ 52,326	$ 43,380	$ 149,011	$ 123,104

Note 5 - Revenue From Contrac_7

Note 5 - Revenue From Contracts With Customers - Capitalized Cost to Obtain Contracts, Current and Noncurrent (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current	$ 4,646	$ 4,223
Noncurrent	$ 8,991	$ 8,391

Note 6 - Intangible Assets, N_3

Note 6 - Intangible Assets, Net (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Amortization of Intangible Assets	$ 1.3	$ 1.7	$ 4.5	$ 5

Note 6 - Intangible Assets, N_4

Note 6 - Intangible Assets, Net - Carrying Value of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Cost	$ 30,443	$ 30,443
Amortization of intangible assets	(28,464)	(23,938)
Net Book Value	1,979	6,505
Intangible assets, net	2,019	6,545
Intangible Assets Not Subject to Amortization [Member]
Intangible assets not subject to amortization	$ 40	$ 40
Developed Technology Rights [Member]
Weighted Average Life (Year)	4 years 6 months	4 years 6 months
Weighted Average Remaining Life (Year)	3 months 18 days	10 months 24 days
Cost	$ 28,556	$ 28,556
Amortization of intangible assets	(26,768)	(22,463)
Net Book Value	$ 1,788	$ 6,093
Patents [Member]
Weighted Average Life (Year)	14 years	14 years
Weighted Average Remaining Life (Year)	1 year 10 months 24 days	2 years 8 months 12 days
Cost	$ 1,387	$ 1,387
Amortization of intangible assets	(1,196)	(1,121)
Net Book Value	$ 191	$ 266
Noncompete Agreements [Member]
Weighted Average Life (Year)	2 years	2 years
Weighted Average Remaining Life (Year)		7 months 6 days
Cost	$ 500	$ 500
Amortization of intangible assets	(500)	(354)
Net Book Value	$ 0	$ 146

Note 6 - Intangible Assets, N_5

Note 6 - Intangible Assets, Net - Expected Amortization Expense in Future Periods (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
2022 (remaining three months)	$ 537
2023	590
2024	452
2025	240
2026	160
Total expected future amortization expense	$ 1,979	$ 6,505

Note 7 - Leases (Details Textua

Note 7 - Leases (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Note 7 - Leases (Details Textual) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Lease, Expense	$ 3.7	$ 4.2	$ 11.1	$ 12.5

Note 7 - Leases - Supplemental

Note 7 - Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash payments included in the measurement of lease liabilities	$ 12,258	$ 10,776
Lease liabilities arising from obtaining right-of-use assets	$ 3,401	$ 1,739

Note 7 - Leases - Weighted Aver

Note 7 - Leases - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details)	Sep. 30, 2022	Dec. 31, 2021
Weighted average remaining lease term (Year)	4 years	4 years 6 months
Weighted average discount rate	5%	4.80%

Note 9 - Stockholders' Equity_3

Note 9 - Stockholders' Equity and Stock-based Compensation (Details Textual) - USD ($) $ in Thousands					3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 08, 2022	Oct. 28, 2021	Jun. 09, 2021	Apr. 27, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Share-Based Payment Arrangement, Expense					$ 13,291	$ 9,463	$ 37,856	$ 56,218
Share-Based Payment Arrangement, Accelerated Cost								$ 27,300
Stock Repurchased and Retired During Period, Shares (in shares)							1,613,000	875,000
Stock Repurchased and Retired During Period, Value							$ 212,800	$ 94,900
Stock Repurchase Program, Remaining Authorized Repurchase Amount					259,000		259,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total					21,800		$ 21,800
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)							2 years 10 months 24 days
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total					66,200		$ 66,200
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)							2 years 8 months 12 days
Share-Based Payment Arrangement, Expense					1,000		$ 2,900
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)							278,000
Restricted Stock Units (RSUs) [Member] \| Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		33.33%
Share-Based Compensation, Percentage Of Shares That Will Vest Upon Trigger		100%
Performance-based Restricted Stock Units [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total					3,300		$ 3,300
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)							1 year 9 months 18 days
Performance-based Restricted Stock Units [Member] \| Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)		73,000
Share-Based Compensation, Percentage Of Shares That Will Vest Upon Trigger		100%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		3 years
Share-based Compensation Termination Period Trigger (Month)		12 months
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)									34,000
Performance-based Restricted Stock Units [Member] \| President and Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)				9,671
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)				3 years
ESPP Shares [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total					$ 900		$ 900
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)							4 months 24 days
Minimum [Member] \| Restricted Stock Units (RSUs) [Member] \| Performance Shares, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Target Percentage		0%
Minimum [Member] \| Performance-based Restricted Stock Units [Member] \| President and Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Target Percentage				0%
Maximum [Member] \| Restricted Stock Units (RSUs) [Member] \| Performance Shares, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Target Percentage		200%
Maximum [Member] \| Performance-based Restricted Stock Units [Member] \| President and Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Target Percentage				200%
The 2012 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)	3,072,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)					2,911,000		2,911,000
The 2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)					554,700		554,700
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)			600,000
Share-based Compensation Arrangement by Share-based Payment Award, Offering Period (Month)			6 months
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			85%
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)							45,300
The 2021 Employee Stock Purchase Plan [Member] \| Minimum [Member]
Employee Stock Purchase Plan, Percentage of Eligible Compensation Contributable			1%
The 2021 Employee Stock Purchase Plan [Member] \| Maximum [Member]
Employee Stock Purchase Plan, Percentage of Eligible Compensation Contributable			15%

Note 9 - Stockholders' Equity_4

Note 9 - Stockholders' Equity and Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock-based compensation	$ 13,291	$ 9,463	$ 37,856	$ 56,218
Cost of Sales [Member]
Stock-based compensation	1,384	986	3,739	2,702
Research and Development Expense [Member]
Stock-based compensation	3,236	2,723	10,064	7,520
Selling and Marketing Expense [Member]
Stock-based compensation	2,495	1,642	6,829	4,356
General and Administrative Expense [Member]
Stock-based compensation	$ 6,176	$ 4,112	$ 17,224	$ 41,640

Note 9 - Stockholders' Equity_5

Note 9 - Stockholders' Equity and Stock-based Compensation - Share-based Compensation and Stock Options Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares		Dec. 31, 2021 USD ($) $ / shares shares
Balance (in shares) \| shares	1,838
Weighted average exercise price, balance (in dollars per share) \| $ / shares	$ 66.05
Weighted Average Remaining Contractual Life Balance (Year)	6 years 6 months		6 years
Aggregate intrinsic value \| $	$ 67,404		$ 130,791
Granted (in shares) \| shares	438
Weighted average exercise price, Granted (in dollars per share) \| $ / shares	$ 130.97
Exercised (in shares) \| shares	(429)	[1]
Weighted average exercise price, Exercised (in dollars per share) \| $ / shares	$ 54
Canceled (in shares) \| shares	(122)
Weighted average exercise price, Canceled (in dollars per share) \| $ / shares	$ 112.66
Balance (in shares) \| shares	1,725		1,838
Weighted average exercise price, balance (in dollars per share) \| $ / shares	$ 82.24		$ 66.05
Vested and expected to vest (in shares) \| shares	1,512
Weighted average exercise price, Vested and expected to vest (in dollars per share) \| $ / shares	$ 76.56
Vested and Expected to vest, weighted average remaining contractual life (Year)	6 years 1 month 6 days
Vested and Expected to vest, aggregate intrinsic value \| $	$ 66,670
Exercisable (in shares) \| shares	948
Weighted average exercise price, Exercisable (in dollars per share) \| $ / shares	$ 50.98
Exercisable, weighted average remaining contractual life (Year)	4 years 3 months 18 days
Exercisable, aggregate intrinsic value \| $	$ 63,624

[1]Included 348 thousand shares of PSOs.

Note 9 - Stockholders' Equity_6

Note 9 - Stockholders' Equity and Stock-based Compensation - Share-based Compensation, Restricted Stock and Restricted Stock Units (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Cancelled, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 116.40
Expected to vest, number of shares (in shares) \| shares	700
Expected to vest, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 112.22
Restricted Stock Units (RSUs) [Member]
Balance, number of shares (in shares) \| shares	917	[1]
Balance, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 104.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) \| shares	278
Granted, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 133
Vested, number of shares (in shares) \| shares	(248)
Vested, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 99.25
Cancelled, number of shares (in shares) \| shares	(122)
Balance, number of shares (in shares) \| shares	825	[1]
Balance, weighted average grant date fair value (in dollars per share) \| $ / shares	$ 114.13

[1]Includes 34 thousand PSUs granted to certain executive officers in 2021.

Note 9 - Stockholders' Equity_7

Note 9 - Stockholders' Equity and Stock-based Compensation - Schedule of Repurchase Agreements (Details) - USD ($) $ in Billions	Sep. 30, 2022	May 04, 2022	Nov. 03, 2021	Feb. 10, 2021	May 07, 2020	Oct. 30, 2019	Oct. 30, 2018	Feb. 12, 2018
Authorized Dollar Value	$ 0.9							$ 0.1
Additional Authorized Dollar Value		$ 0.2	$ 0.2	$ 0.1	$ 0.1	$ 0.1	$ 0.1

Note 10 - Net Income Per Shar_2

Note 10 - Net Income Per Share - Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income	$ 27,660	$ 26,596	$ 25,410	$ 27,769	$ 21,142	$ 228	$ 79,666	$ 49,139
Basic weighted average shares (in shares)	38,317			38,925			38,680	39,077
Stock options (in shares)	658			852			715	851
Restricted stock units (in shares)	242			161			236	219
Employee stock purchase plan (in shares)	3			0			3	0
Diluted weighted average shares (in shares)	39,220			39,938			39,634	40,147
Basic (in dollars per share)	$ 0.72			$ 0.71			$ 2.06	$ 1.26
Diluted (in dollars per share)	$ 0.71			$ 0.70			$ 2.01	$ 1.22

Note 10 - Net Income Per Shar_3

Note 10 - Net Income Per Share - Anti-dilutive Net Income Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive securities (in shares)	567	594	651	612
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	554	543	614	531
Restricted Stock Units (RSUs) [Member]
Antidilutive securities (in shares)	0	50	30	81
Employee Stock Purchase Plan Shares [Member]
Antidilutive securities (in shares)	13	1	7	0

Note 11 - Income Taxes (Details

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Tax Expense (Benefit), Total	$ 6,178	$ 4,282	$ 19,637	$ 10,554
Effective Income Tax Rate Reconciliation, Percent, Total	18.30%	13.40%	19.80%	17.70%
Unrecognized Tax Benefits, Ending Balance	$ 10,300		$ 10,300		$ 9,700
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 5,300		$ 5,300		$ 4,900

Note 12 - Segment Information_3

Note 12 - Segment Information and Information About Geographic Area (Details Textual)	9 Months Ended
	Sep. 30, 2022
Number of Operating Segments	1
Number of Reportable Segments	1

Note 12 - Segment Information_4

Note 12 - Segment Information and Information About Geographic Area - Revenue and Property and Equipment, Net by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues	$ 125,561	$ 104,934	$ 358,874	$ 301,392
Property and equipment, net and Operating leases - right of use asset	85,389		85,389		$ 98,870
UNITED STATES
Revenues	75,234	63,599	214,318	184,722
Property and equipment, net and Operating leases - right of use asset	60,174		60,174		66,440
INDIA
Property and equipment, net and Operating leases - right of use asset	17,515		17,515		20,401
Non-US [Member]
Revenues	50,327	$ 41,335	144,556	$ 116,670
Other Geographic Areas [Member]
Property and equipment, net and Operating leases - right of use asset	$ 7,700		$ 7,700		$ 12,029

Note 13 - Subsequent Events (De

Note 13 - Subsequent Events (Details Textual) - Developed Technology Rights [Member] - Subsequent Event [Member] - USD ($) $ in Millions		18 Months Ended
	Oct. 04, 2022	Apr. 04, 2024
Finite-lived Intangible Assets Acquired	$ 10
Payments to Acquire Intangible Assets	$ 8.5
Forecast [Member]
Payments to Acquire Intangible Assets		$ 1.5